Congenital Syphilis

Presenter: Rosalyn Plotzker, MD, MPH & Elizabeth Kessler, MPH

Online CME Credit

Fee: Free

Provides 1.00 hours of CE/CME credit (Presented: July 20, 2023; Reviewed August 24, 2023; Expires August 24, 2024)


This training is in collaboration with the California Prevention Training Center and the Pacific AIDS Education and Training Center-Nevada. Prevention of congenital syphilis (CS) is critical, given that untreated syphilis during pregnancy may lead to miscarriage, stillbirth, blindness, deafness, and/or bone deformities in infants. While CS can be fully prevented through timely syphilis screening and adequate treatment during prenatal care, the number of CS cases in Nevada and the United States continues to rise. This webinar will discuss the epidemiology of syphilis in Nevada, and review the screening updates, pathophysiology, and treatment.

Learning Objectives

Following participation in this course, participants should be able to:

  • Describe congenital syphilis epidemiology
  • Discuss screening updates and POT screening
  • Explain the pathophysiology, manifestations, and treatment for congenital syphilis

The Pacific AETC-NV offers engaging and interactive online learning opportunities to increase healthcare providers' knowledge and awareness of HIV and STI-related health topics. To view all session topics available, please click on Pacific AETC Nevada’s E-Learning page for more online and on-demand learning opportunities.


Rosalyn Plotzker, MD, MPH
Assistant Professor | UCSF Dept. of Epidemiology and Biostatistics | Clinical Faculty| California Prevention Training Center | Provider | UCSF Anal Neoplasia, Clinic, Research and Education (ANCRE) Center | Public Health Medical Officer| CDPH STD Control Branch

Elizabeth Kessler, MPH
OPHIE Surveillance Manager | Office of Public Health Investigations and Epidemiology | Division of Public and Behavioral Health | Nevada Department of Health and Human Services

The Pacific AETC is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award $3,887,700.00. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. For more information, please visit